Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Tackling false trial data in China

China makes huge contributions to global pharma manufacturing and drug discovery, but there is a problem at the heart of Chinese research that threatens the integrity of the sector: according to a government investigation, more than 80% of Chinese clinical trial data is “fabricated”. How has this situation come about, what damage has been done, and how can China crack down on falsified clinical data?

Go Top